Dietary management practices in phenylketonuria across European centres

被引:71
作者
Ahring, Kirsten [2 ]
Belanger-Quintana, Amaya [3 ]
Dokoupil, Katharina [4 ]
Ozel, Hulya Gokmen [5 ]
Lammardo, Anna Maria [6 ]
MacDonald, Anita [1 ]
Motzfeldt, Kristina [7 ,8 ]
Nowacka, Maria [9 ]
Robert, Martine [10 ]
van Rijn, Margreet [11 ]
机构
[1] Childrens Hosp, Birmingham B4 6NH, W Midlands, England
[2] Kennedy Inst, Ctr PKU, Glostrup, Denmark
[3] Hosp Ramon & Cajal, Serv Pediat, Unidad Enfermendades Metab, E-28034 Madrid, Spain
[4] Univ Munich, Dr von Hauner Childrens Hosp, Dept Metab & Nutr, Munich, Germany
[5] Hacettepe Univ, Dept Nutr & Dietet, Ankara, Turkey
[6] Univ Milan, Dept Pediat, San Paolo Hosp, Milan, Italy
[7] Univ Hosp, Rikshosp, Dept Pediat Res, Oslo, Norway
[8] Univ Hosp, Rikshosp, Div Pediat, Oslo, Norway
[9] Natl Res Inst Mother & Child, Dept Pediat, Warsaw, Poland
[10] Hop Univ Enfants Reine Fabiola, Nutr & Metab Unit, Brussels, Belgium
[11] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Sect Metab Dis, NL-9713 AV Groningen, Netherlands
关键词
Phenylketonuria; Diet; Nutrition; Phenylalanine; RANDOMIZED CONTROLLED-TRIAL; SAPROPTERIN DIHYDROCHLORIDE; TREATED PHENYLKETONURIA; PHENYLALANINE; PKU; OUTCOMES;
D O I
10.1016/j.clnu.2009.03.004
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Dietary phenylalanine restriction is the cornerstone of phenylketonuria (PKU) management. However, there are no European consensus guidelines for its optimal dietary care. Methods: Detailed information on the routine dietary management of PKU was obtained from 10 European centres using structured questionnaires. Each centre was represented by one dietitian/nutritionist or physician (European Nutritionist Expert Panel). Results: All centres screened for PKU within the first 10 days of life. PKU prevalence was highest in Turkey. The training, roles and responsibilities of dietitians and nutritionists varied widely; in some centres dietitians were responsible for managing the diet, while in others this was performed by a physician. There were marked differences in target blood phenylalanine concentrations, the dosages of protein substitutes, systems for allocating daily phenylalanine allowance, and the definition of foods that could be eaten without restriction ('free foods'). Eighty percent (n = 8/10) of centres encouraged breastfeeding together with protein substitute in infants with PKU. Conclusions: important differences exist among centres across Europe in the dietary management of PKU, and in Support systems designed to assist patients in managing their diets. Further studies are needed to compare different dietary treatments with the aim of identifying best practice to optimise phenylalanine control and dietary adherence. (C) 2009 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 33 条
[1]   BH4 responsiveness associated to a PKU mutation with decreased binding affinity for the cofactor [J].
Aguado, Cristina ;
Perez, Belen ;
Jose Garcia, M. ;
Belanger-Quintana, Amaya ;
Martinez-Pardo, Mercedes ;
Ugarte, Magdalena ;
Desviat, Lourdes R. .
CLINICA CHIMICA ACTA, 2007, 380 (1-2) :8-12
[2]  
Ahring KK, 2008, J INHERIT METAB DIS, V31, P84
[3]   Prevalence of stimulant use for attentional dysfunction in children with phenylketonuria [J].
Arnold, GL ;
Vladutiu, CJ ;
Orlowski, CC ;
Blakely, EM ;
DeLuca, J .
JOURNAL OF INHERITED METABOLIC DISEASE, 2004, 27 (02) :137-143
[4]   Plasma phenylalanine in patients with phenylketonuria self-managing their diet [J].
Bekhof, J ;
van Rijn, M ;
Sauer, PJJ ;
Ten Vergert, EM ;
Reijngoud, DJ ;
van Spronsen, FJ .
ARCHIVES OF DISEASE IN CHILDHOOD, 2005, 90 (02) :163-164
[5]  
Bowersox J, 2001, PEDIATRICS, V108, P972
[6]   Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997 [J].
Burgard, P ;
Bremer, HJ ;
Bührdel, P ;
Clemens, PC ;
Mönch, E ;
Przyrembel, H ;
Trefz, FK ;
Ullrich, K .
EUROPEAN JOURNAL OF PEDIATRICS, 1999, 158 (01) :46-54
[7]   The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin):: a phase II, multicentre, open-label, screening study [J].
Burton, B. K. ;
Grange, D. K. ;
Milanowski, A. ;
Vockley, G. ;
Feillet, F. ;
Crombez, E. A. ;
Abadie, V. ;
Harding, C. O. ;
Cederbaum, S. ;
Dobbelaere, D. ;
Smith, A. ;
Dorenbaum, A. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 (05) :700-707
[8]   Randomised controlled trial of essential fatty acid supplementation in phenylketonuria [J].
Cleary, M. A. ;
Feillet, F. ;
White, F. J. ;
Vidailhet, M. ;
MacDonald, A. ;
Grimsley, A. ;
Maurin, N. ;
de Baulny, H. Ogier ;
Rutherford, P. J. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2006, 60 (07) :915-920
[9]  
DELOOY A, 2007, 1 DIETS C PLYM UK
[10]   Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: Intelligence and executive function [J].
DeRoche, Kathryn ;
Welsh, Marilyn .
DEVELOPMENTAL NEUROPSYCHOLOGY, 2008, 33 (04) :474-504